Innate Pharma OverviewInnate Pharma Net Income
Profitability analysis for IPHA.
Quarterly Net Income
-$27.63M
↓ 11.82% YoY
As of Dec 2025
Annual Net Income (TTM)
-$86.06M
↓ 249.89% YoY
Trailing 12 months ending Dec 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...